Abstract | BACKGROUND: OBJECTIVES: DESIGN: The patients were randomly assigned to either baclofen (5%) cream or placebo immediately after surgery and then every 12 h for 14 days. PATIENTS: A total of 66 patients with third- and fourth-degree hemorrhoids undergoing open hemorrhoidectomy were randomly assigned to this trial. SETTING: This study was conducted at a single educational hospital. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcomes were intensity of pain, measured with a visual analog scale, and the analgesic requirement, measured by the amount of the acetaminophen consumption. RESULTS: No significant difference was found in baseline characteristics between the two groups. Postoperative pain score of the baclofen group was significantly lower on week 1 (P = 0.01) and week 2 (P = 0.02) than the placebo group. Similarly, patients in the baclofen group consumed significantly less analgesic medication on week 1 (P = 0.025) and week 2 (P = 0.024) than the control group. CONCLUSION:
|
Authors | Shahram Ala, Mina Alvandipour, Majid Saeedi, Mohaddeseh Mansourifar, Mahila Monajati, Afshin Shiva |
Journal | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
(J Gastrointest Surg)
Vol. 24
Issue 2
Pg. 405-410
(02 2020)
ISSN: 1873-4626 [Electronic] United States |
PMID | 30783957
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Analgesics
- GABA-B Receptor Agonists
- Acetaminophen
- Baclofen
|
Topics |
- Acetaminophen
(therapeutic use)
- Administration, Topical
- Adult
- Analgesics
(therapeutic use)
- Baclofen
(administration & dosage, therapeutic use)
- Double-Blind Method
- Female
- GABA-B Receptor Agonists
(administration & dosage, therapeutic use)
- Hemorrhoidectomy
(adverse effects)
- Hemorrhoids
(surgery)
- Humans
- Male
- Middle Aged
- Pain Measurement
- Pain, Postoperative
(drug therapy, etiology)
- Prospective Studies
|